Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

July 11, 2022

Study Completion Date

July 11, 2022

Conditions
Glioma, MalignantGlioma Glioblastoma Multiforme
Interventions
DIAGNOSTIC_TEST

[68Ga]Ga-PSMA-11 PET/CT

The PET/CT image acquisition was performed from the skull to the mid-thigh (3-min per bed position, 3 iterations, 21 subsets) with a CT scan (120 kV, 170mAs reference) with dose modulation for anatomic correlation (CARE dose 4D) and attenuation correction on a Biograph 64 TruePoint (Siemens Medical Solutions Inc., USA) 60 min post injection of \[68Ga\]Ga-PSMA-11 (2 MBq per kg body weight).

Trial Locations (1)

02-091

Nuclear Medicne Department Medical University of Warsaw, Warsaw

All Listed Sponsors
lead

Medical University of Warsaw

OTHER

NCT05896449 - Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin | Biotech Hunter | Biotech Hunter